$125k fine for conduct breach

Following a complaint by rival pharmaceutical company AstraZeneca, the Medicines Australia Code of Conduct Committee found that MSD’s use of the term "Now with patient outcomes data" in promotional materials to doctors constituted a breach of the code.

AstraZeneca argued the claim “Now with patient outcomes data” constituted promotion of Vytorin for the reduction of cardiovascular events, which is not an approved indication.

The phrase referred to